Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

7 stock offering and the receipt of $10 million from AstraZeneca upon the signing of the companies' research collaboration and license agreement.

Palatin Technologies' management will discuss the fourth quarter and year end financial results for the fiscal year ended June 30, 2007 and provide an update on corporate developments during a conference call and webcast on September 18, 2007 at 10:00 a.m. ET.

Conference Call and Webcast Access Information

-- Q4-Fiscal Year 2007 Conference Call - Live 9/18/2007 at 10:00 a.m. ET

Domestic Dial-In Number 1-866-454-4203

International Dial-In Number 1-913-312-6693

-- Q4-Fiscal Year 2007 Conference Call - Replay 9/18-9/25/2007

Domestic Dial-In Number 1-888-203-1112

International Dial-In Number 1-719-457-0820

Enter Pass Code I.D. # 4280242

-- Webcast Live and Replay Access http://www.palatin.com

The webcast and replay can be accessed by logging on to the investors

section of Palatin Technologies' website at http://www.palatin.com.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' websit
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... 14, 2014 As pet owners drew up their lists of ... wrote: "Take better care of my furry companion." Nowadays there are ... top-brand carrying cases to take the little canine or feline darlings ... compelled to buy some pricey toys at the pet store. But ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), ... commercializing innovative therapies addressing major unmet medical needs ... the Notice of Allowance from the United States ... RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Services Inc., leads a videocast discussion with top executives on ... to Asia. , ... (PRWEB) November ... Atlanta, Georgia, Jim Miller, president of PharmSource Information Services Inc., ...
... Arpida,announced today that it is refocusing all projects and ... is to be seen as a,consequence of the negative recommendation ... 20 November 2008 regarding the,approval of Iclaprim in the U.S. ... of the FDA advisory board,s recommendation the Arpida,board intends to ...
... sailing a spacecraft by the optical force of the sun,s light. ... the oversized sails that have been tried. Now a team led ... Science has shown that the force of light indeed can ... to nano-proportions. , Their work opens the door to a ...
Cached Biology Technology:PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS 2Arpida to Restructure and Focus on Key Projects 2'The photon force is with us': Harnessing light to drive nanomachines 2
(Date:4/24/2014)... International Glossina Genome Initiative (IGGI) has produced the first ... morsitans . The blood-sucking insect is the sole transmitter ... sub-Saharan Africa. The vast store of genetic data will ... and provide insights into the tsetse fly,s unique biology. ... insect world: it feeds exclusively on the blood of ...
(Date:4/24/2014)... 2014D-ribose is a commercially important sugar used as ... starting compound for synthesizing riboflavin and several antiviral ... to increase the bacteria,s ability to produce D-ribose ... industrial-scale production of this valuable chemical, as described ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/24/2014)... Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have identified ... system to discriminate between viral and endogenous RNAs ... they take control of cellular metabolism and hijack ... This process is dependent on viral RNA molecules ... of RNA viruses) and/or newly synthesized in the ...
Breaking Biology News(10 mins):Genetic code of the deadly tsetse fly unraveled 2Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3
... from Boston College have developed a new class of ... that reveals the telltale signs of cellular death, particularly ... in the current electronic edition of the Journal ... by Assistant Professor of Chemistry Jianmin Gao successfully grafted ...
... fuel economy is on everyone,s minds these days. The ... is no exception. For several years, the transit authority, ... fleet in an effort to curb the transportation system,s fuels costs. ... hybrids is the question the University of Houston has been asked ...
... of California, Berkeley, are offering hope to the 10 percent ... often high-pitched ringing or buzzing in the ears that can ... Their new findings, published online last week in the journal ... several new approaches to treatment, including retraining the brain, and ...
Cached Biology News:Small molecule receptor detects lipid's telltale sign of cell death 2University of Houston to test local buses for fuel efficiency 2Tinnitus discovery could lead to new ways to stop the ringing 2Tinnitus discovery could lead to new ways to stop the ringing 3
... The Synaptic Vesicles Isolation Kit ... preparing an enriched synaptic vesicle fraction. ... hypo-osmotic lysis of the synaptosomes, and ... density gradient. The kit also contains ...
... The Ultra Silica Bead Kit has been designed ... gels and solutions. Features Ultra ... minutes Uniform silica beads are easy to resuspend ... DNA Highly pure DNA (suitable for PCR) ...
... simple and efficient method for purification of DNA ... DNA fragments selectively absorbed in the spin column ... at room temperature for PCR product with equal ... of DNA can be purified with a single ...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: